Literature DB >> 22537447

Will there be a vaccine to protect against the hepatitis C virus?

Benoît Callendret1, Christopher M Walker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22537447      PMCID： PMC3862033          DOI： 10.1053/j.gastro.2012.02.010

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  26 in total

1.  Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins.

Authors:  Harel Dahari; Stephen M Feinstone; Marian E Major
Journal:  Gastroenterology       Date:  2010-06-02       Impact factor: 22.682

Review 2.  Evolving epidemiology of hepatitis C virus.

Authors:  D Lavanchy
Journal:  Clin Microbiol Infect       Date:  2011-02       Impact factor: 8.067

Review 3.  Adaptive immunity to the hepatitis C virus.

Authors:  Christopher M Walker
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

Review 4.  Hepatitis C virus genotype 4 therapy: progress and challenges.

Authors:  Sanaa M Kamal
Journal:  Liver Int       Date:  2011-01       Impact factor: 5.828

5.  Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.

Authors:  Sharon E Frey; Michael Houghton; Stephen Coates; Sergio Abrignani; David Chien; Domenico Rosa; Piero Pileri; Ranjit Ray; Adrian M Di Bisceglie; Paola Rinella; Heather Hill; Mark C Wolff; Viola Schultze; Jang H Han; Bruce Scharschmidt; Robert B Belshe
Journal:  Vaccine       Date:  2010-07-07       Impact factor: 3.641

Review 6.  Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses.

Authors:  Michael Houghton
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

7.  Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt.

Authors:  F DeWolfe Miller; Laith J Abu-Raddad
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

8.  Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.

Authors:  William O Osburn; Brian E Fisher; Kimberly A Dowd; Giselle Urban; Lin Liu; Stuart C Ray; David L Thomas; Andrea L Cox
Journal:  Gastroenterology       Date:  2009-09-24       Impact factor: 22.682

Review 9.  Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence.

Authors:  Barbara Rehermann
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

10.  Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX vaccine: a phase I study in healthy volunteers.

Authors:  Debbie Drane; Eugene Maraskovsky; Rebecca Gibson; Sue Mitchell; Megan Barnden; Alan Moskwa; David Shaw; Barbara Gervase; Stephen Coates; Michael Houghton; Russel Basser
Journal:  Hum Vaccin       Date:  2009-03-15
View more
  1 in total

1.  Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago.

Authors:  Desarae Echevarria; Alexander Gutfraind; Basmattee Boodram; Jennifer Layden; Jonathan Ozik; Kimberly Page; Scott J Cotler; Marian Major; Harel Dahari
Journal:  Vaccine       Date:  2019-04-05       Impact factor: 3.641
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.